The Clinical Use of N-Acetylcysteine in Other Medical Disorders
Author:
Frye Richard Eugene
Publisher
Springer Singapore
Reference136 articles.
1. Abdel-Baky RM, Ali MA, Abuo-Rahma GEAA, AbdelAziz N (2017) Inhibition of urease enzyme production and some other virulence factors expression in Proteus mirabilis by N-acetyl cysteine and Dipropyl disulphide. Adv Exp Med Biol 973:99–113 2. Agusti AG, Togores B, Ibanez J, Raurich JM, Maimo A, Bergada J, Marse P, Jorda R (1997) Effects of N-acetylcysteine on tissue oxygenation in patients with multiple organ failure and evidence of tissue hypoxia. Eur Respir J 10(9):1962–1966 3. Ahola T, Fellman V, Laaksonen R, Laitila J, Lapatto R, Neuvonen PJ, Raivio KO (1999) Pharmacokinetics of intravenous N-acetylcysteine in pre-term new-born infants. Eur J Clin Pharmacol 55(9):645–650 4. Ahola T, Lapatto R, Raivio KO, Selander B, Stigson L, Jonsson B, Jonsbo F, Esberg G, Stovring S, Kjartansson S, Stiris T, Lossius K, Virkola K, Fellman V (2003) N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial. J Pediatr 143(6):713–719. https://doi.org/10.1067/s0022-3476(03)00419-0 5. Akerlund B, Jarstrand C, Lindeke B, Sonnerborg A, Akerblad AC, Rasool O (1996) Effect of N-acetylcysteine(NAC) treatment on HIV-1 infection: a double-blind placebo-controlled trial. Eur J Clin Pharmacol 50(6):457–461
|
|